From: CTpathway: a CrossTalk-based pathway enrichment analysis method for cancer research
ID | Pathway name | #Node | PS | P-value | FDR | Da | Ga | Ga | Pa | La |
---|---|---|---|---|---|---|---|---|---|---|
hsa05200 | Pathways in cancer | 454 | 0.187 | 1.37×10−8 | 2.52×10−6 | √ |  | √ | √ |  |
hsa05152 | Tuberculosis | 175 | 0.164 | 1.69×10−8 | 2.52×10−6 |  | √ |  |  | √ |
hsa05140 | Leishmaniasis | 72 | 0.233 | 2.58×10−8 | 2.57×10−6 | √ | √ | √ | √ | √ |
hsa05133 | Pertussis | 52 | 0.239 | 1.03×10−7 | 3.09×10−6 | √ | √ | √ |  | √ |
hsa04110 | Cell cycle | 124 | 0.237 | 6.88×10−8 | 3.09×10−6 | √ | √ | √ | √ |  |
hsa04510 | Focal adhesion | 199 | 0.201 | 4.49×10−8 | 3.09×10−6 | √ |  |  |  |  |
hsa05166 | Human T-cell leukemia virus 1 infection | 233 | 0.196 | 9.77×10−8 | 3.09×10−6 | √ |  |  |  | √ |
hsa04512 | Ascorbate and ECM-receptor interaction | 81 | 0.181 | 8.56×10−8 | 3.09×10−6 | √ |  |  |  | √ |
hsa04610 | Complement and coagulation cascades | 55 | 0.171 | 8.71×10−8 | 3.09×10−6 | √ |  | √ | √ | √ |
hsa05150 | Staphylococcus aureus infection | 39 | 0.171 | 8.20×10−8 | 3.09×10−6 | √ | √ |  |  | √ |